Atlas Trials

RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)

Clinical trial NCT06926244 · RECRUITING

Trial details

NCT number
NCT06926244
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
RECRUITING
Study type
OBSERVATIONAL
IgA Nephropathy (IgAN)
Start date
2025-06-23
Primary completion
2028-04-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.